Praluent (Sanofi-Aventis U.S. LLC)
Welcome to the PulseAid listing for the Praluent drug offered from Sanofi-Aventis U.S. LLC. This PCSK9 Inhibitor [EPC],PCSK9 Inhibitors [MoA],Antibodies, Monoclonal [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Sanofi-Aventis U.S. LLC |
| NON-PROPRIETARY NAME: | alirocumab |
| SUBSTANCE NAME: | ALIROCUMAB |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | PCSK9 Inhibitor [EPC],PCSK9 Inhibitors [MoA],Antibodies, Monoclonal [Chemical/Ingredient] |
| ROUTE: | SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2015-07-24 |
| END MARKETING DATE: | 0000-00-00 |
Praluent HUMAN PRESCRIPTION DRUG Details:
| Item Description | Praluent from Sanofi-Aventis U.S. LLC |
| LABELER NAME: | Sanofi-Aventis U.S. LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 75(mg/mL) |
| START MARKETING DATE: | 2015-07-24 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0024-5901_27748799-89b9-4496-bbba-2c2f43889eb9 |
| PRODUCT NDC: | 0024-5901 |
| APPLICATION NUMBER: | BLA125559 |
Other ALIROCUMAB Pharmaceutical Manufacturers / Labelers:
